期刊文献+

原发性胆汁性肝硬化诊治进展 被引量:10

Research advances in diagnosis and treatment of primary biliary cirrhosis
暂未订购
导出
摘要 原发性胆汁性肝硬化(PBC)是一种以肝内小胆管进行性、非化脓性炎症为特征的慢性胆汁淤积性疾病,可导致肝纤维化及肝硬化。其病因和发病机制尚不清楚,疾病发生和进展认为是多因素的,大多是环境因素作用于遗传易感者。熊去氧胆酸是被认为是唯一有效的治疗药物,但完全应答率不是特别高。结合国内外文献,对PBC诊断和治疗作一简要综述。 Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease, characterized by progressive non -pyogenic inflammation in the small intrahepatic bile ducts, and can cause hepatic fibrosis and liver cirrhosis. The etiology and pathogenesis of PBC remain un- known. The development and progression of PBC are caused by various factors, and the major factor is environmental factors acting on pa- tients with genetic susceptibility. Ursodesoxycholic acid is thought to be the only effective drug, but the complete response rate remains low. This article reviews the diagnosis and treatment of PBC with reference to the literature in the world.
作者 宁惠明 欧强
出处 《临床肝胆病杂志》 CAS 2016年第4期802-805,共4页 Journal of Clinical Hepatology
关键词 肝硬化 胆汁性 诊断 治疗 综述 liver cirrhosis, biliary diagnosis therapy review
  • 相关文献

参考文献33

二级参考文献63

  • 1韩丽利,路遥,张艳丽,申戈,张璐,邱国华,吴云忠,杨民,李明慧,谢尧,成军,徐道振.自身抗体及生化学指标对自身免疫性肝病筛查及诊断的意义[J].中华临床医师杂志(电子版),2012,6(20):49-53. 被引量:6
  • 2闫惠平,庄辉,刘燕敏,冯霞,檀玉芬,刘妍,张欣,赵春惠.原发性胆汁性肝硬化患者的免疫学特点分析[J].中华肝脏病杂志,2005,13(1):12-16. 被引量:49
  • 3许蓓,谢青.自身免疫性肝炎的研究进展[J].肝脏,2007,12(3):200-203. 被引量:7
  • 4田耀洲,宣估,曹鹏,等.化肝通络方对原发性胆汁性肝硬化的抗纤维化作用及机制探讨[C]//第二十五届全国中西医结合消化系统疾病学术会议论文集.南昌:中国中西医结合学会消化系统疾病专业委员会,2013:430.
  • 5Hazzan R, Tur-Kaspa IL Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid [ J]. J Clin Gastroenterol,2010,44(5 ) :371-373.
  • 6Takeuchi Y, Ikeda F, Fujioka S, at al. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid [ J ]. J Gastroenterol Hepato1,2011,26 (9) : 1395-1401.
  • 7Testi R,D'Ambrosio D,De Maria R,et al. The CD69 receptor: a multipurpose ceil-surface trigger for hematopoietic cells [J]. Immunol Today, 1994,15 (10) :479-483.
  • 8Gonzalez-Garcia A, Merida I, Marfinez-AC, et al , Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway [ J ] . J Biol Chem, 1997,272 ( 15 ) : 10220-10226.
  • 9Li X, Yuan FL, Lu WG, et al. The role of imerleukin-17 in mediating joint destruction in rheumatoid arthritis [ J]. Biochem Biophys Res Commun ,2010,397 (2) : 131-135.
  • 10KohnoM, Tsutsumi A, Matsui H, et al. Interleukin-17 gene expression in patients with rheumatoid arthritis [ J ]. Mod Rheumatol,2008,18 ( 1 ) : 15-22.

共引文献47

同被引文献92

引证文献10

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部